Aurobindo Expects Sandoz Completion ‘Very Soon’

Aurobindo Pharma says its billion-dollar purchase of Sandoz’s US business is on track for completion “very soon” as it announced net first-quarter net profit that rocketed by nearly 40%, powered by strong US sales.

Coming soon
Completion of the Sandoz deal is imminent, Aurobindo says • Source: Shutterstock

Aurobindo said its purchase of Sandoz’ US business, which would make it the second-biggest player in the country’s prescription market, should be completed “very soon” as it reported a nearly 40% leap in net profit that beat market estimates and sent its shares soaring.

Last September, Aurobindo, betting big on the world’s largest drug market, announced it was buying the US dermatology business and...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business